login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
PELTHOS THERAPEUTICS INC (PTHS) Stock News
USA
-
NYSE Arca
- NYSEARCA:PTHS -
US1711262048
-
Common Stock
22.33
USD
-0.02 (-0.09%)
Last: 12/18/2025, 2:39:24 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
PTHS Latest News, Press Relases and Analysis
All
Press Releases
14 days ago - By: Pelthos Therapeutics, Inc.
Pelthos Therapeutics Signs Major Pharmacy Benefit Manager Agreement Expanding Patient Access to ZELSUVMI™ (berdazimer) Topical Gel, 10.3%
16 days ago - By: Pelthos Therapeutics, Inc.
Pelthos Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
a month ago - By: Investor's Business Daily
- Mentions:
LGND
OABI
RPRX
TVTX
...
Why Ligand Pharma, A Hidden Name Behind Two Big Drugs, Is Up 88% This Year
a month ago - By: Pelthos Therapeutics, Inc.
Pelthos Therapeutics Announces Third Quarter Fiscal 2025 Financial Results
a month ago - By: Pelthos Therapeutics, Inc.
Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing
a month ago - By: Benzinga
- Mentions:
ECC
VINP
INV
VTGN
...
Earnings Scheduled For November 13, 2025
a month ago - By: Benzinga
- Mentions:
LGND
BFRI
EXCLUSIVE: Pelthos Secures Rights To Antimicrobial Drug, Raises $18 Million To Support Commercial Launch
a month ago - By: Pelthos Therapeutics, Inc.
Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025
2 months ago - By: Pelthos Therapeutics, Inc.
Pelthos Therapeutics Launches Moms Against Molluscum Movement to Unite Families Affected by Molluscum Contagiosum
3 months ago - By: ACCESS Newswire
- Mentions:
UXIN
JG
PRSO
SPCB
...
Presenting at the Investor Summit Q3 2025 on September 16; Watch the Live Stream for Free
3 months ago - By: Pelthos Therapeutics, Inc.
Pelthos Therapeutics to Participate in Upcoming September Investor Conferences
4 months ago - By: Pelthos Therapeutics, Inc.
Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update
5 months ago - By: Stocktwits
- Mentions:
LGND
Pelthos, Ligand Gain After Launch Of First Prescription-At-Home Treatment For Water Warts
6 months ago - By: Channel Therapeutics Corporation
- Mentions:
CHRO
Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement
Please enable JavaScript to continue using this application.